![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Catalyst Clinical Research will manage Moleculin's US clinical trial to study the ability of Annamycin to treat soft tissue sarcoma (STS) that has metastasized to the lungs.
Lead Product(s): Annamycin
Therapeutic Area: Oncology Product Name: L-ANN
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Moleculin Biotech
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 01, 2021